D) Assume the asthma patient has a chronic disease form ofasthma. At the cellular level, which cells are now likely to havemigrated into the lung tissue? (4pts) Name 2types:
E) What factors do the cells named in part D secrete that maylead to air sac damage or damage to the elasticity of the lungtissue? (2pts) Name 2 factors:
F) The patient is now treated with NUCALA (Mepolizumab) for theasthma that they have. What exactly does NUCALA do to lessen thedisease? Focus on which cells it may alter thebehavior of and how it works. (2pts)
G) The patient also is prescribed Advair. Focusing on the immunesystem altering component of Advair, fluticasone, whatclass of drug is it and what does itdo at a general level? (2pts)
